Q2 Solutions is one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques and multi-dimensional LC for the quantitation of biotherapeutics, peptides, proteins, and biomarkers. Our team has the experience and knowledge in development and validation of small and mid-size peptides to proteins, fusion proteins and monoclonal antibodies. The development of these assays is followed by method validation and sample analysis consistent with global regulatory requirements and governed by SOPs.
Download the presentation to learn more about LC-MS/MS method development at Q2 Solutions.
Jack Henion, Ph.D., Vice President, R&D
Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers